Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00DSV
|
||||
| Former ID |
DIB011990
|
||||
| Drug Name |
Polynoma-1
|
||||
| Synonyms |
Polyvalent melanoma vaccine, Vaccinoma
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [1] | ||
| Company |
Vaccinoma Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Tyrosine oxidase | Target Info | [1] | ||
| Melanoma-associated antigen 3 | Target Info | [1] | |||
| MART-1 melanoma antigen | Target Info | [1] | |||
| BioCyc Pathway | (S)-reticuline biosynthesis | ||||
| Eumelanin biosynthesis | |||||
| L-dopachrome biosynthesis | |||||
| KEGG Pathway | Tyrosine metabolism | ||||
| Riboflavin metabolism | |||||
| Metabolic pathways | |||||
| Melanogenesis | |||||
| PathWhiz Pathway | Riboflavin Metabolism | ||||
| Tyrosine Metabolism | |||||
| WikiPathways | Dopamine metabolism | ||||
| References | |||||
| REF 1 | An immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. Polynoma. 2015. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.